Filarial Diseases

Emodepside multiple ascending dose Phase I

NCT03383614  |  United Kingdom

A phase 1 multiple-dose-escalation study to investigate safety, tolerability, and pharmacokinetics of emodepside after oral dosing in healthy male subjects.

 

Emodepside relative bioavailability study of immediate release tables and solutions Phase I

NCT03383523  |  United Kingdom

This study evaluates 2 new immediate release-tablet formulations of emodepside and they will be compared to the oral liquid service formulation used in the emodepside single-ascending dose study.

 

Emodepside single ascending dose Phase I

NCT02661178  |  United Kingdom | Completed

Emodepside single-ascending dose for onchocerciasis.

 

Last update: February 2018